ERG and neoplasm: Among others, researchers have linked this molecular feature with increased tumor grade and even increased lethality in patients who underwent radical prostatectomy [33,34], with the risk being more pronounced when tumors exhibited a concurrent loss of ERG immunoexpression [35].